Clinical Trial Update: Effect of 15% Eflornithine Hydrochloride Cream on African-American Males With Pseudofolliculitis Barbae [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating 15% eflornithine hydrochloride cream for Pseudofolliculitis barbae in African-American men has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pseudofolliculitis Barbae

Drugs mentioned

• Eflornithine hydrochloride cream (eflornithine hydrochloride)

Snippet

Sponsor: Hordinsky, Maria K., MD | Conditions: Pseudofolliculitis Barbae | Phase 2 | Status: COMPLETED